PharPoint Research, Inc., an innovative drug development service provider offering expertise in project management, clinical monitoring, data management and biostatistics services, announces that it is PharPoint Research is one of the 25 recipients of the 2012 North Carolina Companies to Watch awards provided by CED, the Southeast’s largest entrepreneurial supports organization. This award honors growth oriented, second-stage North Carolina based companies that demonstrate high performance, growth, and innovation in their respective industries. Per CED, the 25 recipients collectively added jobs at an annual rate of 35% between 2008 and 2011, and grew revenue by an annual rate of 41 percent during the same period, totaling $191 million in revenue.
“PharPoint Research is excited about being one a CED Companies to Watch award winners”, said PharPoint’s President and CEO Art Holmes. He added, “PharPoint was founded on providing high quality, tailored solutions to not only meet but exceed our clients’ expectations. We believe that this award is evidence that our core commitment of client responsiveness and superior quality remains a viable model in our highly competitive clinical trials service industry.”